Screening of fetal trisomies 21, 18 and 13 by non invasive prenatal testing
Galician Agency for Health Knowledge Management (avalia-t)
Record ID 32018001155
English
Authors' objectives:
The purpose of the assessment is to evaluate the relative effectiveness and safety of noninvasive prenatal testing (NIPT) for the screening of fetal trisomy 21, trisomy 18 and trisomy 13 in comparison to first trimester combined screening, evaluating the potential benefits and risks of the different screening pathways.
Details
Project Status:
Completed
URL for project:
https://eunethta.eu/wp4-otca03-screening-fetal-trisomies-21-18-13-non-invasive-prenatal-testing-now-available/
Year Published:
2018
URL for published report:
https://eunethta.eu/wp4-otca03-screening-fetal-trisomies-21-18-13-non-invasive-prenatal-testing-now-available/
Requestor:
HTA agencies
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
MeSH Terms
- Chromosome Disorders
- Trisomy
- Trisomy 13 Syndrome
- Trisomy 18 Syndrome
- Maternal Serum Screening Tests
- Down Syndrome
- Genetic Testing
- Prenatal Diagnosis
Contact
Organisation Name:
European Network for Health Technology Assessment
Contact Email:
eunethta@zinl.nl
Copyright:
CC-BY-NC: You may copy, distribute, display, perform, and modify and use the EUnetHTA work for any purpose other than commercially unless you get your permission first.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.